Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CytomX Therapeutics, Inc. | 38,000 | reported | 11 Jun 2025 | tx 3+152,000 |
| Karyopharm Therapeutics Inc. | 15,508 | reported | 21 May 2026 | tx 4+138,695 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 15,508 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | CytomX Therapeutics, Inc. | 38,000 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 4,600 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 50,587 | 0.00 USD | deriv |
| 15 May 2024 | GRANT_AWARD | CytomX Therapeutics, Inc. | 38,000 | 0.00 USD | deriv |
| 20 Mar 2024 | GRANT_AWARD | CytomX Therapeutics, Inc. | 76,000 | 0.00 USD | deriv |
| 31 Aug 2023 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 68,000 | 0.00 USD | deriv |